Sign in
Instrumentation & Devices Symposium 2
Annual Meeting Talks
2020
96-Week Visual and Expanded Anatomical Outcomes of Brolucizumab Versus Aflibercept in Patients With nAMD: Results From HAWK and HARRIER
Chirag D. Jhaveri, MD, FASRS
2019
Silicone Oil (SO) Microdroplets in Repackaged Bevacizumab Syringes: Identification, Quantification, and Strategies For Reducing Clincal Impact
John D Pitcher, MD
On Demand Cases, Courses, and Papers
2017
Category: AMD-Neovascular